Skip to content
DataLookout
Menu

NCT07817160

Pelvic Floor Dysfunction in Pulmonary Systemic Sclerosis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Trial completed Show 4 more changesShow less
    • Final enrollment: 37 participants (planned 67)
    • Primary completion date changed from estimate of Sep 20, 2026 to Oct 6, 2026
    • Study completion date changed from estimate of Oct 1, 2026 to Oct 6, 2026
    • Site details revised
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Pelvic Floor Dysfunction - Pelvic Floor Distress Inventory-20 Total Score
Timeframe: Baseline

Secondary (14)

Pulmonary Function Test - Forced Expiratory Volume in One Second
Pulmonary Function Test - Forced Vital Capacity
Pulmonary Function Test - Diffusing Capacity of the Lungs for Carbon Monoxide
Maximum Inspriratory Pressure
Maximum Expiratory Pressure
Show 9 moreShow less
Functional Exercise Capacity - 6-Minute Walk Test
Trunk Flexor Endurance - McGill Core Endurance Test
Trunk Extensor Endurance - McGill Core Endurance Test
Lateral Trunk Endurance - McGill Core Endurance Test
Cough-Related Quality of Life - Leicester Cough Questionnaire
Modified Medical Research Council Dyspnea Scale
Sexual Function - Arizona Sexual Experiences Scale
Disease-Related Functional Status - Scleroderma Health Assessment Questionnaire
Pelvic Floor Health Knowledge - Pelvic Floor Health Knowledge Test

Arms and interventions

Other: Pelvic Floor Health Knowledge Assessment, Pelvic Floor Dysfunction Assessment, Core Endurance Assessment, Body Composition Assessment, Sexual Function Assessment, Respiratory Function, Functional Exercise Capacity Assessment, Functional Status Assessment

Sites

1 site in 1 country

  • Istanbul Faculy of Medicine-Department of Pulmonary MedicineIstanbul, Istanbul, Turkey (Türkiye)